T1	Outcomes 0 43	Efficacy, tolerability and pharmacokinetics
T2	Outcomes 1406 1424	median CD4% change
T3	Outcomes 1506 1528	safety or tolerability
T4	Outcomes 1657 1701	permanent discontinuation of study treatment
T5	Outcomes 1833 1865	NFV pharmacokinetic measurements
T6	Outcomes 2025 2062	pharmacokinetics for NVP, RTV and d4T
T7	Outcomes 2286 2298	tolerability
